186 related articles for article (PubMed ID: 24563332)
1. PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: possible involvement of mast cells.
Bhatt DK; Gupta S; Olesen J; Jansen-Olesen I
Cephalalgia; 2014 Oct; 34(11):877-86. PubMed ID: 24563332
[TBL] [Abstract][Full Text] [Related]
2. PACAP and its receptors in cranial arteries and mast cells.
Jansen-Olesen I; Hougaard Pedersen S
J Headache Pain; 2018 Feb; 19(1):16. PubMed ID: 29460121
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine.
Syed AU; Koide M; Braas KM; May V; Wellman GC
J Mol Neurosci; 2012 Nov; 48(3):574-83. PubMed ID: 22766684
[TBL] [Abstract][Full Text] [Related]
4. Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38.
Baun M; Pedersen MH; Olesen J; Jansen-Olesen I
Cephalalgia; 2012 Mar; 32(4):337-45. PubMed ID: 22421901
[TBL] [Abstract][Full Text] [Related]
5. The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery.
Boni LJ; Ploug KB; Olesen J; Jansen-Olesen I; Gupta S
Cephalalgia; 2009 Aug; 29(8):837-47. PubMed ID: 19220306
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat.
Baun M; Hay-Schmidt A; Edvinsson L; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2011 Nov; 670(1):186-94. PubMed ID: 21914446
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the closed cranial window model in rats by intracarotid infusion of signalling molecules implicated in migraine.
Gupta S; Bhatt DK; Boni LJ; Olesen J
Cephalalgia; 2010 Jan; 30(1):27-36. PubMed ID: 19438925
[TBL] [Abstract][Full Text] [Related]
8. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery.
Chan KY; Baun M; de Vries R; van den Bogaerdt AJ; Dirven CM; Danser AH; Jansen-Olesen I; Olesen J; Villalón CM; MaassenVanDenBrink A; Gupta S
Cephalalgia; 2011 Jan; 31(2):181-9. PubMed ID: 20974589
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
11. Effect of pituitary adenylate cyclase-activating polypeptide-27 on cerebral hemodynamics in healthy volunteers: A 3T MRI study.
Ghanizada H; Al-Karagholi MA; Arngrim N; Ghanizada M; Larsson HBW; Amin FM; Ashina M
Peptides; 2019 Nov; 121():170134. PubMed ID: 31449829
[TBL] [Abstract][Full Text] [Related]
12. Aging-Induced Modulation of Pituitary Adenylate Cyclase-Activating Peptide- and Vasoactive Intestinal Peptide-Induced Vasomotor Responses in the Arteries of Mice.
Ivic I; Solymar M; Fulop BD; Hashimoto H; Toth G; Tamas A; Juhasz T; Koller A; Reglodi D
J Vasc Res; 2017; 54(6):359-366. PubMed ID: 29131060
[TBL] [Abstract][Full Text] [Related]
13. Effect of PGD
Sekeroglu A; Jacobsen JM; Jansen-Olesen I; Gupta S; Sheykhzade M; Olesen J; Bhatt DK
Pharmacol Rep; 2017 Feb; 69(1):50-56. PubMed ID: 27898338
[TBL] [Abstract][Full Text] [Related]
14. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
Akerman S; Goadsby PJ
Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
[TBL] [Abstract][Full Text] [Related]
15. PACAP-38 and PACAP(6-38) Degranulate Rat Meningeal Mast Cells
Pedersen SH; la Cour SH; Calloe K; Hauser F; Olesen J; Klaerke DA; Jansen-Olesen I
Front Cell Neurosci; 2019; 13():114. PubMed ID: 30983973
[TBL] [Abstract][Full Text] [Related]
16. Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine.
Akerman S; Goadsby PJ
Sci Transl Med; 2015 Oct; 7(308):308ra157. PubMed ID: 26446954
[TBL] [Abstract][Full Text] [Related]
17. Investigation of carbachol and PACAP38 in a human model of migraine.
Schytz HW
Dan Med Bull; 2010 Dec; 57(12):B4223. PubMed ID: 21122466
[TBL] [Abstract][Full Text] [Related]
18. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
[TBL] [Abstract][Full Text] [Related]
19. The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study.
Rasmussen NB; Deligianni C; Christensen CE; Karlsson WK; Al-Khazali HM; Van de Casteele T; Granhall C; Amin FM; Ashina M
J Headache Pain; 2023 May; 24(1):60. PubMed ID: 37231350
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds.
Grände G; Labruijere S; Haanes KA; MaassenVanDenBrink A; Edvinsson L
J Headache Pain; 2014 Apr; 15(1):22. PubMed ID: 24754925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
